Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database

Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database

Objective: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. Patients and Methods: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was performed using deidentified administrative claims data...

Full description

Bibliographic Details
Main Authors: Hasan Ahmad Hasan Albitar, MD, Holly Van Houten, BA, Lindsey R. Sangaralingham, MPH, Meghan Knoedler, MS, Yahya Almodallal, MBBS, Adham K. Alkurashi, MBBS, Alice Gallo De Moraes, MD, Hector Cajigas, MD, Hillary DuBrock, MD, Deepti Warad, MBBS, Nadir Demirel, MD, Michael Krowka, MD, Waleed Brinjikji, MD, Vivek N. Iyer, MD, MPH
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454820301636

Internet

http://www.sciencedirect.com/science/article/pii/S2542454820301636

Similar Items